Review Article
The Roles of Regulatory B Cells in Cancer
Table 1
The immunophenotype and naming of the regulatory B cells in mouse and human.
| Species | Marker/phenotype | Naming | References |
| Human |
CD24hi CD27+ | B10 cells | [17] | CD19+ CD25hi CD86hi CD1dhi | Bregs | [19] | CD19+ CD24hi CD38hi | Bregs | [18] | CD19+ CD38+ CD1d+ IgM+ CD147+ GrB+ | GrB+ Bregs | [24] |
| Mouse | CD19+ CD5+ CD1dhi | B10 cells | [5] | B220+ CD21int CD62int IgMint CD23hi CD1dhi | CD1dhi MLN B cells | [12] | CD1dhi CD21hi CD23ā CD24hi IgMhi IgDlo | Marginal zone B cells | [13] | CD19+ CD21hi CD23hi CD24hi IgDhi IgMhi CD1dhi | Transitional 2 marginal-zone precursor (T2-MZP) | [13] | Tim-1+ | Tim-1+ Bregs | [14] | CD1dlo CD11blo CD2 1/CD35lo CD25+ CD69+ CD72hi CD185ā CD196+ IgM+ IgD+ | Adipose IL-10+ B cells | [16] | CD19+ B220+ CD25+ | Tumor-evoked regulatory B cells (tBregs) | [53] |
|
|